Abstract
Cerivastatin is a synthetic HMG-CoA reductase inhibitor with high liver selectivity, which lowers plasma cholesterol levels by inhibiting endogenous cholesterol synthesis. In vitro, the affinity of cerivastatin for HMG-CoA reductase was higher than that of lovastatin, simvastatin and pravastatin. This higher enzyme affinity was reflected in vivo, with a lower ED50 (dose causing 50% inhibition) for cerivastatin in rats and beagle dogs compared with lovastatin. Cerivastatin 0.2 mg/day significantly reduced low density lipoprotein (LDL)-cholesterol, total cholesterol and triglyceride levels, and increased high density lipoprotein (HDL)-cholesterol levels, in patients with type IIa hypercholesterolaemia. Available data indicate that cerivastatin has a tolerability profile similar to that of other HMG-CoA reductase inhibitors. No drug interactions were observed when cerivastatin was coadministered with digoxin, warfarin, cimetidine or the antacid magnesium/aluminium hydroxide.
Citations
Oct 5, 2013·European Journal of Medicinal Chemistry·Sukanya PandetiNarender Tadigoppula
Feb 9, 2000·Pharmacology & Therapeutics·A CorsiniF Bernini
Dec 30, 1998·Current Opinion in Lipidology·M Kornitzer
Mar 27, 2002·Biological & Pharmaceutical Bulletin·Kenji MatsuyamaTakahiro Uchida
Dec 26, 2002·Japanese Journal of Pharmacology·Maria SwiatkowskaCzeslaw S Cierniewski
Jun 18, 2002·Pharmacotherapy·Robert A LucasKerry L Butler
Sep 8, 2000·Clinical Pharmacokinetics·W Mück
Mar 29, 2001·Drugs·M H Davidson
Apr 29, 2014·European Journal of Medicinal Chemistry·Satinath SarkarNarender Tadigoppula
Sep 21, 2011·Bioorganic & Medicinal Chemistry Letters·T NarenderG Bhatia
Apr 17, 2007·Journal of Pharmaceutical and Biomedical Analysis·Ramakrishna NirogiVishwottam Kandikere
Jan 2, 2007·Bioorganic & Medicinal Chemistry Letters·T NarenderK Raj
Oct 23, 2012·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·Janki PrasadT Narender
Oct 28, 1999·Endocrinology·J R BurnettM W Huff
Feb 24, 2001·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·L RendersI A Hauser
Oct 3, 1999·The Journal of International Medical Research·M HanefeldN Schmage
Jul 30, 2002·Journal of Toxicology. Clinical Toxicology·Ian M WhyteAndrew H Dawson
Apr 1, 2000·Annals of Internal Medicine·M L RodríguezJ F Navarro
Oct 16, 2008·The Journal of Organic Chemistry·Simon J Teague